Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Cantor Fitzgerald
Baxter
Deloitte
US Department of Justice
Federal Trade Commission
Queensland Health
Harvard Business School

Generated: December 15, 2018

DrugPatentWatch Database Preview

KEPIVANCE Drug Profile

« Back to Dashboard

Summary for Tradename: KEPIVANCE
Patents:38
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for KEPIVANCE

US Patents for KEPIVANCE

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Try a Free Trial THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) ➤ Try a Free Trial RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Try a Free Trial Enzychem Lifesciences Corporation (Seoul, KR) ➤ Try a Free Trial RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Try a Free Trial Innovation Pharmaceuticals Inc. (Beverly, MA) ➤ Try a Free Trial RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Try a Free Trial Biosuccess Biotech Co. Ltd. (Santa Clara, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for KEPIVANCE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2006 00004 Denmark ➤ Try a Free Trial PRODUCT NAME: PALIFERMIN
00217 Netherlands ➤ Try a Free Trial PRODUCT NAME: PALIFERMIN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/05/314/001 20051025
C005/2006 Ireland ➤ Try a Free Trial SPC005/2006: 20061023, EXPIRES: 20190427
/2006 Austria ➤ Try a Free Trial PRODUCT NAME: PALIFERMIN; REGISTRATION NO/DATE: EU/1/05/314/001 20051025
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Harvard Business School
Boehringer Ingelheim
McKesson
AstraZeneca
Johnson and Johnson
Merck
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.